GILEAD SCIENCES HONG KONG LIMITED,成立于2007-09-04。企业目前的经营状态为其他,统一社会信用代码为38505060。通过企知道大数据分析,公司共对外投资了3家企业。 收起 展开自身风险 0 关联企业风险 1 合作风险 0 竞争风险 0 该企业近期暂无相关动态,您可以加入监控,未来动态及时掌握 加入监控 基本...
1Gilead Sciences Hong Kong Limited子公司 2Gilead Sciences GesmbH.子公司 3YM BioSciences Australia Pty. Ltd.子公司 4Gilead Sciences, LLC子公司 5Gilead Sciences India Private Limited子公司 6Gilead Sciences Farmacêutica do Brasil Ltda.子公司
“These data from the clinical trial of sacituzumab govitecan in China is extremely encouraging,” said Bill Grossman, MD, PhD, Senior Vice President, Oncology Clinical Research, Gilead Sciences. “We are confident in the potential of Tr...
Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Gilead has made the decision to require allU.S., Canada, Australia, Singapore, and Hong Kongemployees and contractors to receive the COVID-19 vaccines as a condition of empl...
VANCOUVER, British Columbia, June 7, 2011 /PRNewswire-Asia/ -- Daily Stock Alerts for GT Solar, American Tower, Brocade, JDS Uniphase, Limited Brands, & Gilead Sciences
Gilead Sciences is looking for a QA Specialist III, for the position of Quality Operational Lead, to join our External QA Team. This position will provide QA oversight to PDM Biologics Contract Manufacturing Organizations in support of Drug Product manufacturing activities across clinical or commercial...
Gilead Sciences confirmed in an e-mail to CNN Business that that it is working with health authorities in China on two trials for patients who have been infected with Covid-19, the official name of this particular strain of coronavirus. ...